Recent Updates
Recently added Catalysts
CLDI Positive Sentiment

Scientific Advisory Board Member Interview – Ashok Srivastava, M.D./Ph.D.

Saturday, February 3, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The article features an interview with Dr. Ashok Srivastava, a member of the Scientific Advisory Board at Calidi Biotherapeutics. It emphasizes his contributions and insights into the field of biotherapeutics. This interview is part of a series highlighting the expertise of advisory board members.
Price reaction · baseline $95.988 (2024-02-02 close) · hit after-hours · clean, no other CLDI news in the window
day 0 close
-6.3%
day 1
-2.9%
day 3 · peak
-26%

Market Sentiment Analysis

POSITIVE FACTORS

  • Interview highlights expertise of Dr. Ashok Srivastava.
  • Focus on advancements in biotherapeutics.
  • Strengthens Calidi Biotherapeutics' advisory team.

Full Press Release Details

Scientific Advisory Board Member Interview – Ashok Srivastava, M.D./Ph.D. Interviews & Media February 3, 2024 Next Post Scientific Advisory Board Member Interview – Bernard Fox, Ph.D. Previous Post Calidi Biotherapeutics Announces the Appointment of Three New Members to its Scientific and Medical Advisory Board

Frequently Asked Questions

Who is Dr. Ashok Srivastava?

Dr. Ashok Srivastava is a member of the Scientific Advisory Board at Calidi Biotherapeutics.

What is the focus of the interview?

The interview focuses on Dr. Srivastava's expertise and insights in biotherapeutics.

What company is Dr. Srivastava associated with?

Dr. Srivastava is associated with Calidi Biotherapeutics.

What type of content is featured in the article?

The article features an interview with Dr. Srivastava discussing his contributions.

ShareAdd on Google
Tags: CLDI Viatris Investor Conferences Healthcare Calidi Biotherapeutics Ashok Srivastava Scientific Advisory Board biotherapeutics interview
Last updated: Feb 3, 2024

Biotech snapshot

Cash runway
$4M liquidity · $1M/mo burn
~2 mo
High dilution risk